Retrospective Study
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Jul 14, 2014; 20(26): 8638-8645
Published online Jul 14, 2014. doi: 10.3748/wjg.v20.i26.8638
Table 1 Characteristics of patients undergoing liver resection n (%)
Baseline characteristicBIP (n = 75)CUSA + BIP (n = 53)CLAMP (n = 252)P value
Age1 (yr)54.1 (17-81)50.7 (16-85)53.7 (19-81)0.256
SexMale47 (62.67)33 (62.26)155 (61.51)0.981
Cause of surgeryHCC38 (50.67)20 (37.74)121 (48.02)0.868
Other malignancy14 (18.67)9 (16.98)43 (17.06)
Benign tumour8 (10.66)10 (18.87)29 (11.51)
Intrahepatic stone12 (16.00)11 (20.75)47 (18.65)
Others3 (4.00)3 (5.66)12 (4.76)
Child-PughA56 (74.67)41 (77.36)210 (83.33)0.196
B19 (25.33)12 (22.64)42 (16.67)
ICG-R15< 1567 (89.33)46 (86.79)219 (86.90)0.849
≥ 158 (10.67)7 (13.21)33 (13.10)
Background liverNormal31 (41.33)31 (58.49)130 (51.58)0.359
Chronic hepatitis24 (32.00)12 (22.64)61 (24.21)
Cirrhosis20 (26.67)10 (18.87)61 (24.21)
Level of surgeonChief doctor31 (20.67)29 (27.36)127 (25.20)0.069
Deputy director doctor56 (37.33)40 (37.74)226 (44.84)
Attending doctor63 (42.00)37 (34.90)151 (29.96)
Type of resectionExtended13 (17.33)8 (15.09)35 (13.89)0.347
Hemihepatectomy
Hemihepatectomy33 (44.00)20 (37.74)108 (42.85)
Lobectomy29 (38.67)21 (39.62)92 (36.51)
Segmentectomy04 (7.55)13 (5.16)
Wedge resection004 (1.59)
TumorYes60 (80.00)39 (73.58)193 (76.59)0.689
Tumor conditionSize, < 30 mm14 (23.33)7 (17.95)56 (29.02)0.300
≥ 30 mm46 (76.67)32 (82.05)137 (70.98)
Single36 (60.00)31 (79.49)115 (59.59)0.059
Multiple24 (40.00)8 (20.51)78 (40.41)
Superficial36 (60.00)28 (71.79)141 (73.06)0.151
Deep24 (40.00)11 (28.21)52 (26.94)
Table 2 Surgical outcomes n (%)
OutcomeBIP (n = 75)CUSA+BIP (n = 53)CLAMP (n = 252)P value
Blood loss1 ≤ 1000 mL73 (97.33)48 (90.57)192 (76.19)< 0.001
> 1000 mL2 (2.67)5 (9.43)60 (23.81)
Intraoperative transfusion112 (16.00)7 (13.21)117 (46.43)< 0.001
Blood loss (mL) median2315 (50-1800)328 (50-2000)583 (50-5000)< 0.001
Transfusion of RBC (mL) median37 (0-800)56 (0-1200)69 (0-2800)< 0.001
Operative time (min) median315 (105-965)335 (80-730)265 (60-590)< 0.001
Table 3 The differences in indexes between the groups n (%)
BIP (A), CUSA + BIP (B), CLAMP (C)(A vs B)(B vs C)(A vs C)
P valueP valueP value
Blood loss, > 1000 mL0.973< 0.001< 0.001
Intraoperative transfusion0.662< 0.001< 0.001
Blood loss (mL), median0.670< 0.001< 0.001
Transfusion of RBC (mL), median0.731< 0.001< 0.001
Operative time (min), median0.409< 0.001< 0.001
ComplicationsYes0.7730.0160.015
Abdominal infection1.0000.1530.130
Bile leak0.6350.2600.108
Ascites0.7600.1490.014
Table 4 Postoperative complications n (%)
ComplicationBIPCUSA + BIPCLAMPP value
(n = 75)(n = 53)(n = 252)
Yes23 (30.67)15 (28.30)117 (46.43)0.007
Abdominal infection2 (2.67)1 (1.89)22 (8.73)0.035
Bile leak > 2 wk1 (1.33)1 (1.89)18 (7.14)0.039
Acute liver failure1 (1.33)02 (0.79)0.710
Return to operating room01 (1.89)3 (1.19)0.577
Respiratory failure01 (1.89)2 (0.79)0.448
Bleeding > 500 mL within 24 h1 (1.33)1 (1.89)7 (2.78)0.725
Hyperbilirubinemia3 (4.00)5 (9.43)8 (3.17)0.181
Sepsis002 (0.79)1.000
Ileus003 (1.19)1.000
Pulmonary embolism1 (1.33)01 (0.40)0.561
Hepatorenal syndrome001 (0.40)1.000
30-d postoperative death1 (1.33)02 (0.79)0.710
Deep venous thrombosis001 (0.40)1.000
Pleural effusion4 (5.33)3 (5.66)24 (9.52)0.370
Wound infection16 (21.33)12 (22.64)50 (19.84)0.884
Wound dehiscence002 (0.79)1.000
Pneumonia2 (2.67)2 (3.77)16 (6.35)0.359
Hepatic insufficiency7 (9.33)2 (3.77)20 (7.94)0.432
Ascites1 (1.33)2 (3.77)29 (11.51)0.002
Atelectasis1 (1.33)1 (1.89)3 (1.19)0.928
Table 5 Laboratory values and hospital stay n (%)
Recovery evaluationBIPCUSA+BIPCLAMP1P value
(n = 75)(n = 53)(n = 251)
TB (μmol/L)Pre-15.2 (4.3-360.7)15.5 (4.9-313.9)13.5 (3.5-358.9)0.425
Day 126.5 (4.3-292.1)23.4 (4.3-292.3)25.9 (5.5-321.4)0.771
Day 322.1 (3.9-215.4)18.3 (6.6-422.0)21.9 (5.6-294.6)0.325
ΔTB26.4 (-189.9-160.3)2.9 (-135.3-261.9)6 (-137.7-156.9)0.585
ALT (μmol/L)Pre-32 (11-337)48 (10-579)36 (7-984)0.187
Day 1314 (21-1616)279 (32-1760)200 (16-3449)< 0.001
Day 3136 (17-1717)135 (27-2246)130 (10-1114)0.272
ΔALT285 (-174-1691)84 (-449-2183)84 (-808-1065)0.388
AST (μmol/L)Pre-35 (14-261)40 (6-531)33 (8-698)0.693
Day 1323 (43-1591)294 (20-3182)247 (14-3750)0.109
Day 388 (15-1404)59 (20-2388)72 (12-940)0.143
ΔAST238 (-133-1372)24 (-510-2350)31 (-617-853)0.168
ALB (g/L)3Pre-37.5 ± 6.140.9 ± 5.339.4 ± 5.80.003
mean ± SDDay 126.9 ± 5.629.4 ± 4.326.2 ± 4.9< 0.001
Day 327.2 ± 4.329.9 ± 4.827.5 ± 4.3< 0.001
ΔALB210.3 ± 6.011.0 ± 6.212.0 ± 5.90.078
Hospital stay (d) mean ± SD16.6 ± 7.415.3 ± 9.216.5 ± 9.60.666